Table of Content
Table of Contents
Table of Contents
1 Industry Overview
1.1 Pharma Ophthalmic Industry
Figure Pharma Ophthalmic Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Pharma Ophthalmic
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Pharma Ophthalmic
1.2.2 Downstream
Table Application Segment of Pharma Ophthalmic
Table Global Pharma Ophthalmic Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Pharma Ophthalmic Market by Type
3.1 By Type
3.1.1 Retinal disorders drugs
Table Major Company List of Retinal disorders drugs
3.1.2 Allergic, inflammatory and infective drugs
Table Major Company List of Allergic, inflammatory and infective drugs
3.1.3 Glaucoma drugs
Table Major Company List of Glaucoma drugs
3.1.4 Dry eye drugs
Table Major Company List of Dry eye drugs
3.1.5 Other ophthalmic drugs
Table Major Company List of Other ophthalmic drugs
3.2 Market Size
Table Global Pharma Ophthalmic Market 2016-2020, by Type, in USD Million
Figure Global Pharma Ophthalmic Market Growth 2016-2020, by Type, in USD Million
Table Global Pharma Ophthalmic Market 2016-2020, by Type, in Volume
Figure Global Pharma Ophthalmic Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Pharma Ophthalmic Market Forecast 2021-2026, by Type, in USD Million
Table Global Pharma Ophthalmic Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Novartis (Company Profile, Sales Data etc.)
4.1.1 Novartis Profile
Table Novartis Overview List
4.1.2 Novartis Products & Services
4.1.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Allergan (Company Profile, Sales Data etc.)
4.2.1 Allergan Profile
Table Allergan Overview List
4.2.2 Allergan Products & Services
4.2.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Roche (Company Profile, Sales Data etc.)
4.3.1 Roche Profile
Table Roche Overview List
4.3.2 Roche Products & Services
4.3.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Valeant (Company Profile, Sales Data etc.)
4.4.1 Valeant Profile
Table Valeant Overview List
4.4.2 Valeant Products & Services
4.4.3 Valeant Business Operation Conditions
Table Business Operation of Valeant (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Regeneron (Company Profile, Sales Data etc.)
4.5.1 Regeneron Profile
Table Regeneron Overview List
4.5.2 Regeneron Products & Services
4.5.3 Regeneron Business Operation Conditions
Table Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Santen (Company Profile, Sales Data etc.)
4.6.1 Santen Profile
Table Santen Overview List
4.6.2 Santen Products & Services
4.6.3 Santen Business Operation Conditions
Table Business Operation of Santen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Bayer (Company Profile, Sales Data etc.)
4.7.1 Bayer Profile
Table Bayer Overview List
4.7.2 Bayer Products & Services
4.7.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer (Company Profile, Sales Data etc.)
4.8.1 Pfizer Profile
Table Pfizer Overview List
4.8.2 Pfizer Products & Services
4.8.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Senju (Company Profile, Sales Data etc.)
4.9.1 Senju Profile
Table Senju Overview List
4.9.2 Senju Products & Services
4.9.3 Senju Business Operation Conditions
Table Business Operation of Senju (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Akorn (Company Profile, Sales Data etc.)
4.10.1 Akorn Profile
Table Akorn Overview List
4.10.2 Akorn Products & Services
4.10.3 Akorn Business Operation Conditions
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Pharma Ophthalmic Sales Revenue 2016-2020, by Company, in USD Million
Table Global Pharma Ophthalmic Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Pharma Ophthalmic Sales Revenue Share in 2020, by Company, in USD Million
Table Global Pharma Ophthalmic Sales Volume 2016-2020, by Company, in Volume
Table Global Pharma Ophthalmic Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Pharma Ophthalmic Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Pharma Ophthalmic Market Concentration, in 2020
Figure Europe Pharma Ophthalmic Market Market Concentration, in 2020
Figure Asia-Pacific Pharma Ophthalmic MMarket Concentration, in 2020
Figure South America Pharma Ophthalmic Market Concentration, in 2020
Figure Middle East & Africa Pharma Ophthalmic Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Glaucoma
Figure Pharma Ophthalmic Demand in Glaucoma , 2016-2020, in USD Million
Figure Pharma Ophthalmic Demand in Glaucoma , 2016-2020, in Volume
6.1.2 Demand in Dry eye syndrome
Figure Pharma Ophthalmic Demand in Dry eye syndrome , 2016-2020, in USD Million
Figure Pharma Ophthalmic Demand in Dry eye syndrome , 2016-2020, in Volume
6.1.3 Demand in Retinal diseases
Figure Pharma Ophthalmic Demand in Retinal diseases , 2016-2020, in USD Million
Figure Pharma Ophthalmic Demand in Retinal diseases , 2016-2020, in Volume
6.1.4 Demand in Other ophthalmic indications
Figure Pharma Ophthalmic Demand in Other ophthalmic indications, 2016-2020, in USD Million
Figure Pharma Ophthalmic Demand in Other ophthalmic indications, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Pharma Ophthalmic Demand Forecast 2021-2026, by Application, in USD Million
Figure Pharma Ophthalmic Market Growth 2021-2026, by Application, in USD Million
Figure Pharma Ophthalmic Market Share in 2026, by Application, in USD Million
Table Pharma Ophthalmic Demand Forecast 2021-2026, by Application, in Volume
Table Pharma Ophthalmic Market Growth 2021-2026, by Application, in Volume
Table Pharma Ophthalmic Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Pharma Ophthalmic Production 2016-2020, by Region, in USD Million
Table Pharma Ophthalmic Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Pharma Ophthalmic Market 2016-2020, by Region, in USD Million
Table Global Pharma Ophthalmic Market Share 2016-2020, by Region, in USD Million
Table Global Pharma Ophthalmic Market 2016-2020, by Region, in Volume
Table Global Pharma Ophthalmic Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure North America Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table North America Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure Europe Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table Europe Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure South America Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table South America Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Pharma Ophthalmic Market Forecast 2021-2026, by Region, in USD Million
Table Pharma Ophthalmic Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Figure
List of Table
List of Table
1. Table Upstream Segment of Pharma Ophthalmic
2. Table Application Segment of Pharma Ophthalmic
3. Table Global Pharma Ophthalmic Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Allergic, inflammatory and infective drugs
5. Table Major Company List of Glaucoma drugs
6. Table Major Company List of Dry eye drugs
7. Table Major Company List of Other ophthalmic drugs
8. Table Global Pharma Ophthalmic Market 2016-2020, by Type, in USD Million
9. Table Global Pharma Ophthalmic Market 2016-2020, by Type, in Volume
10. Table Global Pharma Ophthalmic Market Forecast 2021-2026, by Type, in USD Million
11. Table Global Pharma Ophthalmic Market Forecast 2021-2026, by Type, in Volume
12. Table Novartis Overview List
13. Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Allergan Overview List
15. Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Roche Overview List
17. Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Valeant Overview List
19. Table Business Operation of Valeant (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Regeneron Overview List
21. Table Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Santen Overview List
23. Table Business Operation of Santen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Bayer Overview List
25. Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Pfizer Overview List
27. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Senju Overview List
29. Table Business Operation of Senju (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Akorn Overview List
31. Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Global Pharma Ophthalmic Sales Revenue 2016-2020, by Company, in USD Million
33. Table Global Pharma Ophthalmic Sales Revenue Share 2016-2020, by Company, in USD Million
34. Table Global Pharma Ophthalmic Sales Volume 2016-2020, by Company, in Volume
35. Table Global Pharma Ophthalmic Sales Volume Share 2016-2020, by Company, in Volume
36. Table Regional Demand Comparison List
37. Table Major Application in Different Regions
38. Table Pharma Ophthalmic Demand Forecast 2021-2026, by Application, in USD Million
39. Table Pharma Ophthalmic Demand Forecast 2021-2026, by Application, in Volume
40. Table Pharma Ophthalmic Market Growth 2021-2026, by Application, in Volume
41. Table Pharma Ophthalmic Market Share in 2026, by Application, in Volume
42. Table Pharma Ophthalmic Production 2016-2020, by Region, in USD Million
43. Table Pharma Ophthalmic Production 2016-2020, by Region, in Volume
44. Table Global Pharma Ophthalmic Market 2016-2020, by Region, in USD Million
45. Table Global Pharma Ophthalmic Market Share 2016-2020, by Region, in USD Million
46. Table Global Pharma Ophthalmic Market 2016-2020, by Region, in Volume
47. Table Global Pharma Ophthalmic Market Share 2016-2020, by Region, in Volume
48. Table North America Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
49. Table North America Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
50. Table Europe Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
51. Table Europe Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
52. Table Asia-Pacific Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
53. Table Asia-Pacific Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
54. Table South America Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
55. Table South America Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
56. Table Middle East & Africa Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
57. Table Middle East & Africa Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
58. Table Pharma Ophthalmic Market Forecast 2021-2026, by Region, in USD Million
59. Table Pharma Ophthalmic Market Forecast 2021-2026, by Region, in Volume
60. Table Price Factors List